Protection against henipavirus infection by use of recombinant adeno-associated virus-vector vaccines.
about
Hendra virus and Nipah virus animal vaccines.Peri-exposure protection against Nipah virus disease using a single-dose recombinant vesicular stomatitis virus-based vaccine.rAAV/ABAD-DP-6His attenuates oxidative stress-induced injury of PC12 cells.Henipavirus infections: lessons from animal models.Rhabdovirus-based vaccine platforms against henipavirusesIdentification of systemic immune response markers through metabolomic profiling of plasma from calves given an intra-nasally delivered respiratory vaccine.Single-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins.Single-dose replication-defective VSV-based Nipah virus vaccines provide protection from lethal challenge in Syrian hamsters.Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease.AAV Vectors Vaccines Against Infectious Diseases.A recombinant Hendra virus G glycoprotein subunit vaccine protects nonhuman primates against Hendra virus challenge.Henipavirus pathogenesis and antiviral approaches.Henipavirus Encephalitis: Recent Developments and Advances.Intradermal Immunization with rAAV1 Vector Induces Robust Memory CD8(+) T Cell Responses Independently of Transgene Expression in DCs.Understanding the interaction between henipaviruses and their natural host, fruit bats: Paving the way toward control of highly lethal infection in humans.Protection against henipaviruses in swine requires both, cell-mediated and humoral immune response.Protection from Hendra virus infection with Canarypox recombinant vaccine.Bioengineered Viral Platform for Intramuscular Passive Vaccine Delivery to Human Skeletal Muscle
P2860
Q30387821-A0A3DE8C-8869-41BE-9E79-62A83F18D4CAQ33894405-C2FCA6A9-6CFA-482C-BE89-800EABEF36D8Q34128067-EA9A9E1A-E1AD-40F2-AE6D-DAD1124FA995Q34533606-6E033B72-C8A6-4F80-8394-31F887C2295CQ34992537-502E3172-7824-4858-B849-F4B3D2843CC6Q35082519-D8E04744-D88B-44FA-87C7-9D1127AF83ECQ36791009-A08205FE-CC08-4400-8A3C-9C02D9A2DB97Q37418736-9A0E947F-F552-4010-81B5-F42249FCFF73Q37427047-68112978-BF3C-4361-A9E5-BAEC0FB4660DQ37498000-8D3B4A6A-7CF0-4556-BA98-10293BD4B1BCQ37713970-542D1EB9-C5CB-477C-A80A-F01A8EB09B1BQ38337204-3A62B601-C949-4977-9F69-E1A3A88E8658Q38567114-39D919A8-84F4-452C-8DF6-240AB6C7ED1DQ40117829-82BB6393-0F39-4FAB-AE9E-AB673A37364EQ40382705-F99ADC5E-63D9-4ED0-9914-8FC68B1667A2Q40568826-4342D938-A3F3-47EB-AB2C-46615F576A0BQ47105971-7264AAA6-BBC7-4B40-9E78-C46CC48A87D8Q56889545-433E228C-0C7B-4A6D-831B-0C1399D3C242
P2860
Protection against henipavirus infection by use of recombinant adeno-associated virus-vector vaccines.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Protection against henipavirus ...... ociated virus-vector vaccines.
@en
Protection against henipavirus ...... ociated virus-vector vaccines.
@nl
type
label
Protection against henipavirus ...... ociated virus-vector vaccines.
@en
Protection against henipavirus ...... ociated virus-vector vaccines.
@nl
altLabel
Protection against henipavirus ...... sociated virus-vector vaccines
@en
prefLabel
Protection against henipavirus ...... ociated virus-vector vaccines.
@en
Protection against henipavirus ...... ociated virus-vector vaccines.
@nl
P2093
P2860
P50
P356
P1476
Protection against henipavirus ...... sociated virus-vector vaccines
@en
P2093
Aurélie Ploquin
Judit Szécsi
Kien Chai Ong
Kum Thong Wong
Vanessa Guillaume
Véronique Barateau
P2860
P304
P356
10.1093/INFDIS/JIS699
P407
P577
2012-11-21T00:00:00Z